| Absorption |
| Blood-Brain Barrier | BBB+ | 0.9851 |
| Human Intestinal Absorption | HIA+ | 1.0000 |
| Caco-2 Permeability | Caco2+ | 0.8340 |
| P-glycoprotein Substrate | Non-substrate | 0.5999 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.9145 |
| Non-inhibitor | 0.9661 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.8068 |
| Distribution |
| Subcellular localization | Mitochondria | 0.5389 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.8163 |
| CYP450 2D6 Substrate | Non-substrate | 0.8816 |
| CYP450 3A4 Substrate | Non-substrate | 0.6652 |
| CYP450 1A2 Inhibitor | Inhibitor | 0.7734 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.8597 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.8564 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.6261 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.9419 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.6787 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9084 |
| Non-inhibitor | 0.8076 |
| AMES Toxicity | Non AMES toxic | 0.9762 |
| Carcinogens | Non-carcinogens | 0.6873 |
| Fish Toxicity | High FHMT | 0.9142 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.9953 |
| Honey Bee Toxicity | High HBT | 0.6455 |
| Biodegradation | Ready biodegradable | 0.9108 |
| Acute Oral Toxicity | III | 0.9223 |
| Carcinogenicity (Three-class) | Non-required | 0.5272 |